NEW YORK (GenomeWeb) – Immunotherapy and companion diagnostic developer Treos Bio said today it has completed an $8 million private investment round.

The new funding will be used to support an early-stage clinical trial of PolyPEPI, a precision immunotherapy vaccine for colorectal cancer. The company expects to begin the trial this year. It plans to use its companion diagnostics to identify patients that could be likely responders to the vaccine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jun
27
Sponsored by
Roche

This webinar will present data from the FLAURA trial and show the clinical utility of liquid biopsy in identifying non-small-cell lung cancer (NSCLC) patients who may benefit from targeted TKI therapies. 

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.